Viatris, Pacira and the Return of Pain
Earlier today, Viatris agreed to acquire Pacira BioSciences for about $1.65 billion. Most coverage spins it as a generics company pushing into innovative medicines. Indeed, that is one way to interpret this…
Earlier today, Viatris agreed to acquire Pacira BioSciences for about $1.65 billion. Most coverage spins it as a generics company pushing into innovative medicines. Indeed, that is one way to interpret this…
From Pyramid to T, Part 3: What the T-Shaped Organization Means for BD Professionals Using ADP payroll data covering millions of US workers, researchers at Stanford found that employment of…
From Pyramid to T, Part 2: How to Get There, and What Has to Be True In Part 1, I argued that the BD org chart is moving from a…
From Pyramid to T, Part 1: Why AI Is Reshaping the Business Development Organization Every BD&L course I teach has, at some point, at least one participant bring up the…